Medications for panic disorder
Pro Research Analysisby 
Searched over 200M research papers
First-Line Medications for Panic Disorder: SSRIs and Antidepressants
Selective serotonin reuptake inhibitors (SSRIs) are widely recognized as the first-line pharmacological treatment for panic disorder due to their effectiveness and favorable side effect profile compared to older antidepressants like tricyclic antidepressants (TCAs) and monoamine oxidase inhibitors (MAOIs) 1368. Common SSRIs used include paroxetine, fluoxetine, citalopram, escitalopram, and fluvoxamine . Other antidepressants shown to be effective include serotonin-norepinephrine reuptake inhibitors (SNRIs) such as venlafaxine, as well as TCAs (clomipramine, imipramine, desipramine) and MAOIs 2610. These medications help reduce the frequency and severity of panic attacks and are generally recommended for long-term management 36.
Benzodiazepines for Rapid Relief of Panic Symptoms
Benzodiazepines, such as alprazolam, clonazepam, and diazepam, are also effective for panic disorder and are known for their rapid onset of action, making them useful for acute symptom relief 1236+1 MORE. However, their use is limited by the risk of tolerance, dependence, and withdrawal symptoms, which makes them less suitable for long-term treatment 1368. Despite these risks, benzodiazepines are often well-tolerated and associated with lower dropout rates in clinical trials compared to other medication classes 68.
Comparative Efficacy and Tolerability of Medication Classes
Meta-analyses and systematic reviews indicate that most classes of antidepressants (SSRIs, SNRIs, TCAs, MAOIs) and benzodiazepines are more effective than placebo for panic disorder, with little difference in efficacy between classes 68. Some studies suggest that paroxetine and fluoxetine among SSRIs, and alprazolam and diazepam among benzodiazepines, have particularly strong evidence for efficacy . Benzodiazepines may have a slight advantage in tolerability, as measured by lower dropout rates, but SSRIs are generally preferred due to their lower risk of dependence 68.
Alternative and Emerging Medications for Treatment-Resistant Panic Disorder
For patients who do not respond to standard treatments, other options have been explored. These include newer antidepressants like duloxetine, reboxetine, mirtazapine, nefazodone, and inositol, as well as atypical antipsychotics (aripiprazole, olanzapine, risperidone) and anticonvulsants (gabapentin, lamotrigine, levetiracetam, valproate) 457. Preliminary evidence suggests these medications may be beneficial and generally well-tolerated, but more robust clinical trials are needed to confirm their effectiveness and safety 457.
Investigational and Future Therapies
Research into novel treatments for panic disorder is ongoing, with investigational drugs targeting glutamate, orexin, and cannabinoid systems, as well as corticotrophin-releasing factor and neuropeptide pathways 459. While these new approaches show promise in early studies, they are not yet available for clinical use and require further research to establish their efficacy and safety 459.
Conclusion
SSRIs and other antidepressants are the mainstay of long-term pharmacological treatment for panic disorder, while benzodiazepines are effective for rapid symptom relief but carry risks of dependence. Most medication classes are similarly effective, and the choice of treatment should be individualized based on patient needs, side effect profiles, and risk factors. For treatment-resistant cases, alternative medications and investigational therapies may offer hope, but further research is needed to expand the range of effective options.
Sources and full results
Most relevant research papers on this topic